Vol 17 - Numéro 1 Supplément 1 - septembre 2025
P. 1S1-1S82© SPLF
MISSION ATS 2025
Numéro réalisé grâce au soutien institutionnel apporté par GSK à la Mission ATS de la SPLF
Rev. Mal. Respir. actual September 2025; 17(1S1): i. Publication en ligne : 28 September 2025
PDF HTML
Rev. Mal. Respir. actual September 2025; 17(1S1): ii. Publication en ligne : 28 September 2025
PDF HTML accès libre
Rev. Mal. Respir. actual September 2025; 17(1S1): iii. Publication en ligne : 28 September 2025
PDF HTML
ATS, an old lady still very dashing!
F.-X. Blanc
Rev. Mal. Respir. actual September 2025; 17(1S1): 1S1. Publication en ligne : 28 September 2025
Inflammation and asthma: close encounters of the third kind
A.-T. Dinh-Xuan
Rev. Mal. Respir. actual September 2025; 17(1S1): 1S3. Publication en ligne : 28 September 2025
Biotherapies in severe asthma: use in patients poorly represented in clinical trials
L. Pahus
Rev. Mal. Respir. actual September 2025; 17(1S1): 1S7. Publication en ligne : 28 September 2025
Asthma: new molecules at an early stage of development
F.-X. Blanc
Rev. Mal. Respir. actual September 2025; 17(1S1): 1S15. Publication en ligne : 28 September 2025
Changing concepts and diagnostic criteria in COPD
M. Gueçamburu, A.-T. Dinh-Xuan
Rev. Mal. Respir. actual September 2025; 17(1S1): 1S19. Publication en ligne : 28 September 2025
From nicotine to metatine, the tobacco industry persists!
O. Le Rouzic
Rev. Mal. Respir. actual September 2025; 17(1S1): 1S25. Publication en ligne : 28 September 2025
Inhaled toxic substances: news in 2025
M. Georges
Rev. Mal. Respir. actual September 2025; 17(1S1): 1S29. Publication en ligne : 28 September 2025
Pathophysiological developments in primary graft dysfunction in lung transplantation: immunological aspects and therapeutic implications
S. Decaux
Rev. Mal. Respir. actual September 2025; 17(1S1): 1S36. Publication en ligne : 28 September 2025
Non-invasive monitoring of immunological complications in lung transplantation: towards routine use of donor-derived cell-free DNA?
S. Decaux
Rev. Mal. Respir. actual September 2025; 17(1S1): 1S39. Publication en ligne : 28 September 2025
Interstitial lung diseases: advances and therapeutic perspectives
F. Jeny
Rev. Mal. Respir. actual September 2025; 17(1S1): 1S44. Publication en ligne : 28 September 2025
More and more nodules! From screening to diagnosis
J. Delomez
Rev. Mal. Respir. actual September 2025; 17(1S1): 1S50. Publication en ligne : 28 September 2025
Non-malignant pleural diseases: which therapeutic strategy should be adopted in light of recent data?
D. Basille
Rev. Mal. Respir. actual September 2025; 17(1S1): 1S55. Publication en ligne : 28 September 2025
Pulmonary embolism in 2025: personalize for better care
A. Boucly
Rev. Mal. Respir. actual September 2025; 17(1S1): 1S60. Publication en ligne : 28 September 2025
Treatments for obstructive sleep apnea-hypopnea syndrome other than continuous positive airway pressure (CPAP)
S. Pontier-Marchandise
Rev. Mal. Respir. actual September 2025; 17(1S1): 1S66. Publication en ligne : 28 September 2025
News in the obesity - hypoventilation syndrome
S. Pontier-Marchandise
Rev. Mal. Respir. actual September 2025; 17(1S1): 1S71. Publication en ligne : 28 September 2025
Update in the management of acute respiratory failure with high-flow nasal oxygen therapy
C. Girault
Rev. Mal. Respir. actual September 2025; 17(1S1): 1S74. Publication en ligne : 28 September 2025